2 Vascular compromise occurs early in Alzheimer's disease (AD) and other dementias 1-3 . Amyloid  (Areduces cerebral blood flow 4-6 and, as most of the cerebral vasculature resistance is in capillaries 7 , A might mainly act on contractile pericytes on capillary walls 8-10 . Employing human tissue to establish disease-relevance, and rodent experiments to define mechanism, we now show that A constricts brain capillaries at pericyte locations in human subjects with cognitive decline. Applying soluble A  oligomers to live human cortical tissue constricted capillaries. Using rat cortical slices, this was shown to reflect A evoking capillary pericyte contraction, with an EC 50 of 4.7 nM, via the generation of reactive oxygen species and activation of endothelin ET-A receptors. In freshly-fixed diagnostic biopsies from human patients investigated for cognitive decline, mean capillary diameters were less in subjects showing Adeposition than in subjects without A deposition. For patients with Adeposition, the capillary diameter was 31% less at pericyte somata than away from somata, predicting a halving of blood flow Constriction of capillaries by Awill contribute to the energy lack 1-3 occurring in AD, which promotes further Ageneration 11,12 . This mechanism reconciles the amyloid hypothesis 13-15 with the earliest events in AD being vascular 1 .
phosphorylated tau. Of 13 patients (for demographics, see Online Methods), 7 turned out to have A deposition while 6 did not. Specimen images of their vessels and A labelling are shown in Fig. 3a, b . Pericytes were readily identifiable from their PDGFR labelling.
Averaging over 120-140 adjacent fields of view (400 m square in size, randomly placed on each section as a 5x4 grid of squares) in tissue from the two types of patient, with the analyst blinded to the occurrence of A deposition (viewing only the PDGFR image channel), we found that the mean capillary diameter was reduced by 8.1% (p=0.0007) in the patients with A deposition (5121 diameters measured) compared to those without A deposition (3921 diameters measured, Fig. 3c ).
To assess whether this diameter reduction was a non-specific effect of AD, or was pericyte-related, we plotted the capillary diameter measurements as a function of the distance from the nearest PDGFR-labelled pericyte soma (see Online Methods). In patients with no detectable A deposition the capillary diameter increased at locations near pericyte somata compared to at locations far from the soma (~25% larger, slope of line is significantly less than zero, p=3.7x10 -7 for 813 data points from 6 such patients, Fig 3d) . A similar increase in capillary diameter near somata has previously been found in rodent brain capillaries in vivo 9 , and attributed to the presence of the soma inducing more growth of the endothelial tube. In contrast, in patients with A deposition, the capillary diameter was significantly reduced near the pericyte somata compared to locations distant from the somata ( Fig. 3d ; ~30% smaller, slope of line is significantly greater than zero, p=1.6x10 -20 for 1313 data points from 7 patients), as expected if pericytes cause the capillary constriction by contracting their circumferential processes which are mainly located near their somata. This constriction is predicted to reduce flow by ~50% compared to if there were no constriction (see Online Methods).
The subjects were classified by neuropathologists assessing the A-labelled biopsies as having "no A deposition", "moderate A deposition" or "severe A deposition" in the parenchyma (as diffuse deposits and/or as plaques with central amyloid cores, Fig. 3e ). The mean slope from graphs like those in Fig. 3d , for 6 patients with no A deposition, 3 patients with moderate deposition and 4 patients with severe A deposition, showed a progressive change from negative (implying a larger capillary diameter at the soma) to positive (implying a smaller diameter at the soma) as the severity of the Adeposition increased ( Fig. 3f,   p=0 .003 compared with a relationship with zero slope), supporting further the idea that Ais the cause of the capillary constriction. Plotting a similar graph for the slope against the neuropathologist-assessed degree of cerebral amyloid angiopathy or phosphorylated tau labelling, gave a broadly similar trend with disease severity, but with a somewhat less significant p value (0.013 and 0.007 respectively).
To quantify A level more rigorously, we measured light absorption by the peroxidase product generated by the A antibody, in the region where the vessel diameters were measured in each biopsy (see Online Methods; although this measure of A may largely reflect the presence of plaques, it is likely that the soluble A concentration correlates with plaque load). Plotting the slopes of graphs like those in Fig. 3d , for each biopsy, as a function of the amount of A deposition, again showed a monotonic progression from a negative slope to a positive slope as A deposition increased, but with the change of slope occurring more strongly at low levels of A deposition ( Fig. 3g ). Similarly, plotting the value of the capillary diameter at the pericyte soma for each biopsy (extrapolated from the straight line fit) as a function of A deposition showed that the diameter was reduced more strongly by low levels of A, with less further constriction as deposition increased (Fig. 3h ).
Our data demonstrate that, at low nanomolar concentrations, soluble A  oligomers evoke a constriction of human cortical capillaries, mediated by pericytes. Capillaries are the site in the cortical vasculature where most of the resistance to flow is located 7 , and so are the site where diameter changes will reduce blood flow most (although arteries 20 and arterioles 6 are also reported to be constricted by A). In rodents we show that this constriction is the result of reactive oxygen species generation activating endothelin signalling via ET A receptors, which makes pericytes constrict the capillaries. The EC 50 for A's action, 4.7 nM, is comparable to the concentration of soluble Afound in the brain (6 nM, from the TBS fraction in Table 1 of ref. 29) and two factors indicate that the effects seen are pathologically relevant. First, analysing the diameter of capillaries in human patients with cognitive decline, who either showed or lacked deposition of A shows that Alzheimer's pathology leads to capillary constriction specifically at pericytes, with a magnitude that is estimated to reduce blood flow by a factor of at least 2. Second, the magnitude of the capillary constriction in dementia patients increases with the severity of A deposition. Both the reduction of basal blood flow produced by A, and a reduction in the blood flow increase normally produced by neuronal activity 30 (which may also reflect the action of A on pericytes 9 ), will decrease the energy supply to the brain. This in turn increases Aproduction by upregulating -amyloid converting enzyme (-secretase 1, BACE1) 11, 12 .
Consequently, the regulation of pericyte-mediated capillary constriction by Amay act as an amplifying mechanism in a positive feedback loop ( Fig. 4 ), increasing the level of Aand tau aggregation which ultimately lead to the loss of synapses and neurons.
These data suggest several potential therapeutic approaches for early AD, based on the mechanisms generating pericyte constriction. A-evoked generation of reactive oxygen species (ROS) might be targeted, but this would require resolving whether these are generated by resident microglia 23 or perivascular macrophages 24 , and ROS may play important signalling roles in pathways other than the one controlling endothelin effects. A more promising approach, therefore, might be to try to reduce endothelin release (which is presumably from microglia or endothelial cells: the brain cells expressing endothelin strongly) or the effects of endothelin specifically on its type A receptors located on CNS pericytes. This could be achieved, for example, by generating an endothelin receptor blocker which also binds to another target protein on pericytes, such as the proteoglycan NG2. This concept raises the question of whether A also evokes constriction of capillaries in other vascular beds by acting through pericytes, in which case drugs might be usefully targeted at all pericytes, and not just those in the brain. with 20% O 2 /75% N 2 /5% CO 2 , which produces a physiological level of oxygen in the slice near the capillaries being imaged 9 .
Imaging capillaries
Healthy capillaries (<10 m in diameter, mean diameter 5.61±0.03 m (n=299) in rat, and 5.08±0.33 m (n=12) in human, with no rings of arteriolar smooth muscle around them) were selected as previously described 31 , and regions of them were imaged which were in focus in a single image plane over at least 30 m along the length of a capillary and exhibited a candidate pericyte with a bump-on-a-log morphology (Figs. 1e, 2a). A CCD camera was then used to capture images 100 m square during superfusion of drugs.
Capillary diameter was measured from the resulting movies, by an analyst blinded to the time and identity of drug application, by placing a line across the lumen on magnified images. In some experiments pericytes were identified prior to imaging by incubating slices for 30 min in 10 µg/ml isolectin B 4 conjugated to Alexa 488, which binds to -D-galactose residues in the basement membrane secreted by pericytes and endothelial cells, and outlines pericytes 31 . This allowed 2-photon imaging (using a Zeiss LSM710 microscope, excitation wavelength 800 nm) of the endothelial tube and the pericytes on it (Fig. 2b) .
Assessing pericyte death
This was carried out as previously described 9 . Briefly, brain slices (250 m thick) were incubated in a multi-well plate, with oxygen blown gently at the surface, in aCSF, or aCSF with oligomerised A 1-42 or ET-1 added. All extracellular solutions contained isolectin B 4 to label the basement membrane, and hence pericytes which are enveloped by this ( Fig.   1b ), and 7.5 M propidium iodide to label cells with membranes that had become nonspecifically permeable 9 . After 3 hours incubation, slices were fixed in 4% paraformaldehyde, and imaged on a confocal microscope. To avoid counting cells killed by the slicing procedure, quantification of the percentage of pericytes that were dead excluded cells within
Oligomerising A and assessing the form and concentration of A applied
The method employed to generate oligomeric Aβ preparations was modified from that previously described 32 . Synthetic Aβ (Bachem H- Quantification of A peptide concentration was performed using a Pierce BCA protein assay kit (Thermoscientific 23227), calibrated against a known concentration of bovine serum albumin, taking into account the different chromophoric development of albumin and A peptides by multiplying by a factor of 1.51 33, 34 . This showed that the amount of the molecule remaining as soluble monomers and oligomers was 28.7±2.9% (n=4) of the total concentration added for A 1-42 , 39.9±1.5% (n=3) for A , and 43.6±2.3% for scrambled A . Concentrations stated in the text have been corrected for these factors.
The Aβ oligomeric preparations were analysed via SDS-PAGE using 10-20% trisglycine gels (EC61352BOX, Invitrogen). Samples of 50 μg Aβ peptides were added to trisglycine SDS Sample Buffer (LC2676, Invitrogen). Equal volumes of each sample (10 μl) were loaded onto gels along with SeeBluePlus2 (Invitrogen) pre-stained molecular weight markers, and electrophoretically separated at 100 V. Gels were stained for total protein using a SilverXpress Silver Staining kit (LC6100, Invitrogen) according to the manufacturer's protocol. Aβ 1-42 and Aβ 1-40 formed monomers and oligomers, while scrambled Aβ 1-42 formed only monomers (Fig. 1g ).
Human biopsy data
Diagnostic brain biopsies, comprising cortex and subcortical white matter, were (tissue-free) region without any tissue absorption gave values that were 5.8±0.5% larger, which did not materially change the form of the graphs.
The mean age of patients without Aβ deposition was 50.5±5.5 (n=6, 4 women and 2 men), and of those with Aβ deposition was 62.1±4.2 (n=7, 4 women and 3 men, not significantly different, p=0.11). Regressing mean capillary diameter against age from all patients, or from the patients lacking A deposition, showed that there was no significant dependence on age (p=0.5 and p=0.82 respectively).
Images were analysed to assess capillary diameter with the analyst blind to the level of A and tau deposits (viewing only the PDGFR channel). A standard 5x4 grid of 20 squares (each with sides 400 m long) was superimposed on each image, and all capillaries with clearly demarcated endothelial walls visible in each square had their diameter measured. The image squares were treated as the experimental unit for statistical analysis.
Analysis of the diameter as a function of distance from the nearest visible pericyte employed a subset of all the measured diameters, because often no pericyte was visible on some short capillary segments.
Immunohistochemistry of non-biopsy tissue
Human and rat brain slices were fixed in 4% paraformaldehyde for 1 hour, washed 3 Slices were then washed once in PBS containing DAPI nuclear stain (1:50,000) for 10 mins and then washed again in PBS. After cover-slipping, slices were imaged on a Zeiss LSM700 confocal microscope.
Statistics
Data normality was assessed with Shapiro-Wilk tests. Comparisons of normally distributed data were made using 2-tailed Student's t-tests. Equality of variance was assessed with an F test, and heteroscedastic t-tests were used if needed. Data that were not normally distributed were analysed with Mann-Whitney tests. P values were corrected for multiple comparisons using a procedure equivalent to the Holm-Bonferroni method (for N comparisons, the most significant p value is multiplied by N, the 2nd most significant by N-1, 
Calculation of effect of vessel constriction on flow
We assume that pericytes are regularly spaced on capillaries at an interval of 2L. For flow governed by Poiseuille's law, the resistance of a segment of capillary of length L (from a pericyte soma to midway between two pericytes) and radius r 1 is given by k.L/r 1 4 where k is a constant. If A-induced pericyte contraction reduces the capillary diameter from a value of r 1 at the midpoint between pericytes to r 2 near the pericyte soma (see Fig. 3a so the factor by which the resistance is altered (compared to that with a uniform diameter r 1 )
is [1 + (r 1 /r 2 ) + (r 1 /r 2 ) 2 ].(r 1 /r 2 )/3 (1) This was used to calculate the predicted flow reduction to be produced by the 30% pericyte constriction reported at pericyte somata in Fig. 3d and the main text. In reality the flow reduction will be greater because the diameter at the pericyte soma is actually larger than at the midpoint between pericytes in control conditions (Fig. 3d) , and because Poiseuille's law does not apply for small capillary diameters for which the effective blood viscosity increases as the diameter decreases below 10 m 35 .
Data availability
The data generated in the current study are available from the corresponding author on reasonable request 
